EA201892503A1 - Модуляция метаболизма липидов для продуцирования белков - Google Patents

Модуляция метаболизма липидов для продуцирования белков

Info

Publication number
EA201892503A1
EA201892503A1 EA201892503A EA201892503A EA201892503A1 EA 201892503 A1 EA201892503 A1 EA 201892503A1 EA 201892503 A EA201892503 A EA 201892503A EA 201892503 A EA201892503 A EA 201892503A EA 201892503 A1 EA201892503 A1 EA 201892503A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lipid metabolism
modulation
cell
present
protein production
Prior art date
Application number
EA201892503A
Other languages
English (en)
Russian (ru)
Inventor
Джеймс Бадж
Кристофер Марк Смейлз
Таня Найт
Роберт Янг
Original Assignee
Лонца Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лонца Лтд filed Critical Лонца Лтд
Publication of EA201892503A1 publication Critical patent/EA201892503A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0097Oxidoreductases (1.) acting on reduced flavodoxin as donor (1.19)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083Miscellaneous (1.14.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/19Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
    • C12Y114/19001Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EA201892503A 2016-05-03 2017-05-03 Модуляция метаболизма липидов для продуцирования белков EA201892503A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662330973P 2016-05-03 2016-05-03
PCT/EP2017/060484 WO2017191165A1 (en) 2016-05-03 2017-05-03 Modulation of lipid metabolism for protein production

Publications (1)

Publication Number Publication Date
EA201892503A1 true EA201892503A1 (ru) 2019-09-30

Family

ID=58745198

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892503A EA201892503A1 (ru) 2016-05-03 2017-05-03 Модуляция метаболизма липидов для продуцирования белков

Country Status (13)

Country Link
US (3) US10655111B2 (cg-RX-API-DMAC7.html)
EP (1) EP3452608B1 (cg-RX-API-DMAC7.html)
JP (1) JP6959942B2 (cg-RX-API-DMAC7.html)
KR (1) KR102536221B1 (cg-RX-API-DMAC7.html)
CN (1) CN109415748A (cg-RX-API-DMAC7.html)
AU (1) AU2017259010B2 (cg-RX-API-DMAC7.html)
CA (1) CA3023038C (cg-RX-API-DMAC7.html)
EA (1) EA201892503A1 (cg-RX-API-DMAC7.html)
ES (1) ES2938626T3 (cg-RX-API-DMAC7.html)
IL (2) IL262646B (cg-RX-API-DMAC7.html)
MX (1) MX2018013499A (cg-RX-API-DMAC7.html)
SG (1) SG11201809626PA (cg-RX-API-DMAC7.html)
WO (1) WO2017191165A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3452608B1 (en) * 2016-05-03 2022-11-30 Lonza Ltd Modulation of lipid metabolism for protein production
US20210324366A1 (en) * 2018-07-11 2021-10-21 Cornell University Supported plant plasma membrane lipid bilayer on-a-chip
KR20210052389A (ko) 2018-08-27 2021-05-10 리제너론 파마슈티칼스 인코포레이티드 다운스트림 정제에서의 라만 분광법의 사용
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
WO2020084528A1 (en) * 2018-10-24 2020-04-30 Selexis Sa Expression systems, recombinant cells and uses thereof
JP7574206B2 (ja) 2019-03-20 2024-10-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ステロール調節エレメント結合転写因子1(srebf1)阻害剤による上昇した脂質レベルの治療
CN110317799A (zh) * 2019-07-18 2019-10-11 江南大学 一种人源岩藻糖转移酶8的原核表达方法及其产品
CN114746554A (zh) 2019-11-14 2022-07-12 隆萨有限公司 细胞选择的方法
CN115029307A (zh) * 2022-07-28 2022-09-09 吉林大学 一种延缓MSCs衰老的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
ATE386802T1 (de) 1997-06-12 2008-03-15 Novartis Int Pharm Ltd Künstliche antikörperpolypeptide
JP2003516124A (ja) 1999-10-15 2003-05-13 ユニバーシティー オブ マサチューセッツ 標的とした遺伝的干渉の手段としてのrna干渉経路遺伝子
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
AU2001275474A1 (en) 2000-06-12 2001-12-24 Akkadix Corporation Materials and methods for the control of nematodes
WO2002095008A2 (en) * 2001-02-02 2002-11-28 Bayer Corporation Methods of modulating surfactant phospholipid production
US20050106222A1 (en) * 2003-06-11 2005-05-19 Ailor Eric N. Method to increase protein production in culture
AU2005233326B2 (en) 2004-04-16 2010-09-23 Dsm Ip Assets B.V. Fungal promoters for expressing a gene in a fungal cell
ES2864039T3 (es) * 2005-05-20 2021-10-13 Lonza Biologics Plc Expresión de alto nivel de un anticuerpo recombinante en una célula huésped de mamífero
US20080182249A1 (en) * 2006-09-01 2008-07-31 Fox Brian G Expression systems for mammalian and mycobacterial desaturases
WO2009062789A1 (en) * 2007-11-13 2009-05-22 Boehringer Ingelheim Pharma Gmbh & Co Kg Improving the secretory capacity in host cells
WO2010057246A1 (en) * 2008-11-18 2010-05-27 Commonwealth Scientific Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
CN105073995A (zh) * 2013-02-01 2015-11-18 瑟莱克斯公司 增强的转基因表达和加工
JP6676526B2 (ja) * 2013-08-06 2020-04-08 ロンザ バイオロジクス ピーエルシー 組換えタンパク質の生産のための哺乳動物生産細胞の生成のための手段及び方法
EP3452608B1 (en) 2016-05-03 2022-11-30 Lonza Ltd Modulation of lipid metabolism for protein production

Also Published As

Publication number Publication date
JP2019514399A (ja) 2019-06-06
ES2938626T3 (es) 2023-04-13
MX2018013499A (es) 2019-09-11
CN109415748A (zh) 2019-03-01
EP3452608A1 (en) 2019-03-13
SG11201809626PA (en) 2018-11-29
BR112018072434A2 (pt) 2019-02-19
US10655111B2 (en) 2020-05-19
US11434474B2 (en) 2022-09-06
KR102536221B1 (ko) 2023-05-23
KR20190003651A (ko) 2019-01-09
US20200231944A1 (en) 2020-07-23
IL294241B2 (en) 2023-10-01
US20170321194A1 (en) 2017-11-09
IL294241B1 (en) 2023-06-01
IL262646A (en) 2018-12-31
JP6959942B2 (ja) 2021-11-05
IL294241A (en) 2022-08-01
EP3452608B1 (en) 2022-11-30
CA3023038A1 (en) 2017-11-09
US20230047838A1 (en) 2023-02-16
AU2017259010A1 (en) 2018-11-22
WO2017191165A1 (en) 2017-11-09
CA3023038C (en) 2023-03-14
AU2017259010B2 (en) 2021-04-22
IL262646B (en) 2022-08-01

Similar Documents

Publication Publication Date Title
EA201892503A1 (ru) Модуляция метаболизма липидов для продуцирования белков
PH12019500709A1 (en) Anti-lag-3 antibodies and methods of use thereof
EA201791782A1 (ru) 4,6-диаминопиридо[3,2-d]пиримидиновые соединения, модулирующие toll-подобные рецепторы
AU2017263237A1 (en) GDF15 fusion proteins and uses thereof
WO2018049009A3 (en) Modulation of liver genes
MX2019002946A (es) Anticuerpos anti-pd-1 y sus usos.
MY192561A (en) Taurine supplemented cell culture medium and methods of use
EA201991976A1 (ru) Метаболически оптимизированная клеточная культура
MX2021008143A (es) Metodos para cosechar cultivos de celulas de mamifero.
SA520412669B1 (ar) تصنيع ذيفانات عصبية ناتجة عن معاودة الارتباط الجيني من المطثية الوشيقية
WO2014116846A3 (en) Methods and compositions for modulating an immune response
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
EA201890329A1 (ru) СОЕДИНЕНИЯ В КАЧЕСТВЕ МОДУЛЯТОРОВ RORγ
BR112016023769A2 (pt) célula hospedeira recombinante para a expressão de proteínas de interesse
ECSP077898A (es) Métodos y composiciones para modular la adhesión y la tolerancia al estrés en bacterias
EA201892820A1 (ru) Способ стабилизации белков
HK1247958A1 (zh) T淋巴细胞的调节
MX2016009149A (es) Variantes mejoradas de enzimas.
AU2018289493A1 (en) Methods for modulating regulatory T cells, regulatory B cells, and immune responses using modulators of the APRIL-TACI interaction
EA201791918A1 (ru) Модификация белков клеток-хозяев
EA201990758A1 (ru) Способ получения электрокомпетентных дрожжевых клеток и способ применения указанных клеток
MX2020012356A (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
EP4275751A3 (en) Improved naglu fusion protein formulation
EA202190736A1 (ru) Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью
WO2020205626A8 (en) Modulators of cell surface protein interactions and methods and compositions related to same